NIP
ONC icon

Nicholas Investment Partners’s BeOne Medicines Ltd ONC Stock Holding History

Nicholas Investment Partners’s Portfolio ONC Stock Details ONC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q1 		– Sell
-15,299
Closed -$2.15M – 233
2018
Q4 		$2.15M Sell
15,299
-8,783
-36% -$1.16M 0.23% 156
2018
Q3 		$4.15M Sell
24,082
-1,029
-4% -$173K 0.33% 114
2018
Q2 		$3.86M Buy
+25,111
New +$4.48M 0.27% 123

Other funds holding ONC

BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
HA
HHLR Advisors Grand Cayman, Cayman Islands $832M AUM 32.38% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Temasek Holdings
Temasek Holdings Singapore $37.3B AUM 12.6% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Canada Pension Plan Investment Board
Canada Pension Plan Investment Board Toronto Ontario, Ontario, Canada $181B AUM 41.77% 1-Year Est. Return
HIM
Hillhouse Investment Management Grand Cayman, Cayman Islands $3.13B AUM 7.29% 1-Year Est. Return

Nicholas Investment Partners's ONC Position: Q1 2019 in Review

Nicholas Investment Partners sold out of BeOne Medicines Ltd (ONC) in Q1 2019, closing a stake of 15,299 shares — an estimated $2.15M sold.

Nicholas Investment Partners first reported a position in ONC in Q2 2018 and held it in 3 quarters. The position peaked at $4.15M in Q3 2018. 199 funds tracked by Wall St. Rank hold ONC as of Q1 2019.

  • Nicholas Investment Partners reported no remaining BeOne Medicines Ltd position as of Q1 2019 after selling out during the quarter.
  • Nicholas Investment Partners sold 15,299 BeOne Medicines Ltd shares in Q1 2019, an estimated $2.15M.
  • Nicholas Investment Partners first reported a position in BeOne Medicines Ltd in Q2 2018 and held it in 3 quarters.
  • Nicholas Investment Partners's BeOne Medicines Ltd position peaked at $4.15M in Q3 2018.
  • 199 funds tracked by Wall St. Rank held BeOne Medicines Ltd as of Q1 2019.

Based on Nicholas Investment Partners's 13F filing for Q1 2019, filed 15 May 2019.